Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Strategies and concepts on standardization of cardiac marker assays

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 59, Issue 230, 1999, Pages 113-123

  Dati, F ^a   Panteghini, M ^b   Apple, F S ^c   Christenson, R H ^d   Mair, J ^e   Wu, A H ^f  

^a DiaSys Diagnostic Systems   (Germany)

^b SPEDALI CIVILI   (Italy)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f HARTFORD HOSPITAL   (United States)

Author keywords

Cardiac markers; Cardiac troponin I; Cardiac troponin T; CK MB mass; Diagnostic strategies; Markers of cardiac damage; Myoglobin; Reference materials; Standardization

Indexed keywords

CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; HEART MUSCLE INJURY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; BLOOD; CLINICAL CHEMISTRY; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; REFERENCE VALUE; REPRODUCIBILITY; STANDARD;

BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CORONARY DISEASE; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0032617282     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519909168334     Document Type: Conference Paper

References (39)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 1996;28:1328-1428.
2. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995;28:1-29.
3. Wu AHB. Use of cardiac markers as assessed by outcome analysis. Clin Biochem 1997;30:339-350.
4. Henderson AR. An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations. Clin Lab Med 1997;17:625-654.
5. Henderson AR, Krishnan S, Webb S, Cheung CM, Nazir DJ, Richardson H. Proficiency testing of creatine kinase and creatine kinase-2: the experience of the Ontario Laboratory Proficiency Testing Program. Clin Chem 1998;44:124-133.
6. th ed. Philadelphia: Saunders, 1997; Update 3:1-10.
7. th ed. Philadelphia: Saunders, 1997; Update 3:1-10.
8. Jesse RL, Kontos MC. Evaluation of chest pain in the emergency department. Curr Probl Cardiol 1997;4:149-236.
9. Wu AHB. Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta 1998;272:11-21.
10. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-1653.
11. Henderson AR Gerhardt W, Apple FS. The use of biochemical markers in ischemic heart disease: summary of the roundtable and extrapolations. Clin Chim Acta 1998; 272;93-100.
12. Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998;35:80-4.
13. Price CP. Progress in immunoassay technology. Clin Chem Lab Med 1998;36:341-347.
14. Panteghini M, Altinier S, Dolci A, Pagani F, Pergolini P, Vernocchi A, Zaninotto M. Multicenter evaluation of five methods for myoglobin determination. Clin Chem 1998;44(suppl): A121.
15. Panteghini M, Pagani F. Biological variation of myoglobin in serum. Clin Chem 1997;43:2435.
16. Dati F, Hänseler E, Hohnloser S, Hubl W, Katz N, Messinger M, et al. Recommendations on laboratory testing in acute ischemic heart diseases. J Lab Med 1997;21:402-408.
17. Wu AHB, Apple FS, Gibier B, Jesse R, Warshaw M, Valdes R. National Academy of Clinical Biochemistry. Standards of Laboratory Practice. Guidelines for the use of cardiac markers in coronary artery diseases. Presented at the American Association for Clinical Chemistry Annual Meeting, Chicago, IL, August 1998.
18. Panteghini M. IFCC Committee on standardization of markers of cardiac damage: premises and project presentation. Clin Chem Lab Med 1998;36:887-893.
19. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med: submitted 1999.
20. Büttner J. Reference materials and reference methods in clinical chemistry: A challenge to international cooperation. Eur J Clin Chem Clin Biochem 1994; 32:571-577.
21. Dati F. Reference materials and guidelines for standardization of methods in laboratory medicine. In: Clinical laboratory diagnostics: use and assessment of clinical laboratory results. Ed. Thomas L; TH-Books-Verlag: Frankfurt/Main. 1998; pp 1402-1426.
22. Dybkaer R. Reference materials - A main element in a coherent measurement system. Eur J Clin Chem Clin Biochem 1991;29:241-246.
23. nd ed. Eds. Price CP, Newman DJ; Macmillan reference Ltd: London. 1998; pp 245-268.
24. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lovgren T, Severina ME, et al. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-1385.
25. International Organisation for Standardization-ISO. Terms and definitions used in connection with reference materials. ISO Guide 30: 1992.
26. European Committee for Standardization-CEN. In vitro diagnostic systems - Measurement of quantities in samples of biological origin - Description of reference materials. Draft prEN 12287-October 1997.
27. Guidelines for the production and certification of BCR reference materials. European Commission - Directorate General XII. Doc. BCR/48/93 - December 1994.
28. World Health Organisation (WHO). Biological Substances: International standards and reference reagents. WHO Geneva, 1990.
29. Dati F. Quality management and international standardization programs for protein immunoassays. Anticancer Research 1997;17:3161-3164.
30. Johnson AM, Sampson EJ, Blirup-Jensen S, Svendsen PJ. Recommendations for the selection and use of protocols for assignment of values to reference materials. Eur J Clin Chem Clin Biochem 1996;34:279-285.
31. Heuck CC, Magrath D. WHO criteria for the establishment of diagnostic international reference reagents. WHO Bullettin 1994; 72:514-516.
32. World Health Organisation. Guidelines for the preparation, characterisation and establishment of international and other standards and reference reagents for biological substances. WHO Technical Report Series No. 800,1990:181-214.
33. Dybkaer R. Reference procedures and materials in the clinical laboratory. In: Proceedings of the World Congress on Health Technology Standards 1990. Eds. Gunn SWA, O'Riordan NJ. pp. 659-667.
34. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999;45:18-20.
35. Green S, Onoroski M, Moore R, Wu A, Leher M, Vaidya H, and the AACC CK-MB mass assay standardization subcommittee (MB-MASS). Standardization of CK-MB mass immunoassays. Clin Chem 1994;40:1032.
36. Schreiber A, Specht B, Pelsers MMAL, Glatz JFC, Börchers T, Spener F. Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays. Clin Chem Lab Med 1998;36: 283-288.
37. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, et al. Degradation of cardiac troponin 1: implication for reliable immunodetection. Clin Chem 1998;44:2433-2440.
38. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH; Buechler KF, Bodor G, for the AACC Subcommittee on cTnI standardization. Characterisation of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:1198-208.
39. Hertz HS. Development of an international directory of reference methods and reference materials. Eur J Clin Chem Clin Biochem 1995;33:999-1002.